| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |